SCHEMBL20866713

SCHEMBL20866713

Cn1nccc1C(=N)OC(=N)NC1N=C(c2ccccc2)c2ccccc2NC1=O

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 17/20 0.52
▸ CCKAR P32238 11/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24611914 0.88 CCKBR (0.51) CCKBRCCKAR
SCHEMBL24612015 0.88 CCKBR (0.49) CCKBRCCKAR
SCHEMBL24612218 0.85 CCKBR (0.53) CCKBRCCKAR
SCHEMBL20867026 0.84 CCKBR (0.52) CCKBRCCKAR
SCHEMBL20867015 0.84 CCKBR (0.58) CCKBRCCKAR
SCHEMBL20866819 0.83 CCKBR (0.63) CCKBRCCKAR
SCHEMBL20866659 0.83 CCKBR (0.62) CCKBRCCKAR
SCHEMBL20867024 0.82 CCKBR (0.59) CCKBRCCKAR
SCHEMBL20866706 0.81 CCKBR (0.56) CCKBRCCKAR
SCHEMBL20867089 0.81 CCKBR (0.58) CCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback